Clal Biotechnology (Israel) Financial Diagnostics

CBI -- Israel Stock  

ILS 352.90  2.10  0.60%

Clal Biotechnology Industries Ltd diagnostics interface makes it easy to digest most current publicly released information about Clal Biotechnology as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Clal Biotechnology price relationship with some important fundamental indicators such as market cap and management efficiency.

Clal Biotechnology Note

The company recorded loss per share of 0.39. Clal Biotechnology Industries Ltd had not issued any dividends in recent years. Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. Clal Biotechnology operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. For more info on CLAL BIOTECH please contact the company at 972 3 612 1616 or go to http://www.cbi.co.il.

Clal Biotechnology Alerts

Clal Biotechnology is not yet fully synchronised with the market data
The company reported revenue of 35.05 M. Net Loss for the year was (61.27 M) with profit before overhead, payroll, taxes, and interest of 11.03 M.
CLAL BIOTECH has accumulated about 116.91 M in cash with (81.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.
Latest headline from www.haaretz.com: Business in Brief Shares, Dollar Gain After Holiday Weekend

Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 543.78 M.

Profitablity

The company has Profit Margin (PM) of (174.79) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (208.5) % which suggests for every $100 dollars of sales it generated a net operating loss of -2.08.

Management Efficiency

Clal Biotechnology Industries Ltd has return on total asset (ROA) of (4.59) % which means that it has lost $4.59 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (2.14) % meaning that it generated substantial loss on money invested by shareholders.

Stock Holders for Clal Biotechnology

Clal Biotechnology Technical and Predictive Indicators

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Portfolio Center

Also Currentnly Active

Purchased over 100 shares of
a day ago
Traded for 41.84
Purchased over 100 shares of
a day ago
Traded for 28.79
Purchased over 100 shares of
a day ago
Traded for 108.66
Check also Trending Equities. Please also try ETF Directory module to find actively-traded exchange traded funds (etf) from around the world.
Search macroaxis.com